News
Peptide research, protocols, and industry insights from our team.
AOD-9604: A Muscle-Sparing Adjunct to Tirzepatide
The VA's tirzepatide trial for alcoholism could spotlight AOD-9604 as a muscle-sparing peptide. Researchers eye a combination that preserves lean mass
Read articleTirzepatide for AUD: Could AOD-9604 Augment the VA Trial?
The VA's phase II trial of tirzepatide for alcohol use disorder has researchers asking whether AOD-9604 could sharpen the effec...
Read moreAOD-9604 vs Tirzepatide: Compounding Safety After the FDA Vote
The FDA panel vote on tirzepatide compounding has researchers asking if AOD-9604 is a safer alternative. We compare safety data...
Read moreCould AOD-9604 Fill the GLP-1 Gap During Tirzepatide Shortages?
Tirzepatide shortages force metabolic researchers to consider AOD-9604 for weight loss maintenance. This peptide fragment may s...
Read moreTirzepatide After Ramadan: Managing GI Intolerance and Dose Resumption
Researchers conducting independent work should follow institutional protocols and ethics review where applicable. Ramadan fasti...
Read moreFDA Warning Letters to Compounders: What Tirzepatide Researchers Need to Know
FDA warning letters to tirzepatide compounders expose quality failures that ripple across the peptide research supply chain, fr...
Read more